The Indiana Myeloma Registry
Study Details
Study Description
Brief Summary
This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Outcome Measures
Primary Outcome Measures
- Create a repository [5 years]
The primary objective of this study is to provide a mechanism to store comprehensive clinical, genomic, demographic, social, environmental and quality of life data from subjects with plasma cell dyscrasias
Secondary Outcome Measures
- Data collection [5 years]
To collect data related to clonal evolution, tumor microenvironment, clinical outcomes, adverse events, environmental factors and quality of life that will provide the foundation to create hypotheses for future confirmatory studies.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Male or female patients ≥ 18 years of age at the time of informed consent
-
Has been diagnosed with or is suspected to have one of the following:
-
Monoclonal Gammopathy of Undetermined Significance (MGUS)
-
Smoldering Multiple Myeloma
-
Multiple Myeloma
-
Bony or Soft Tissue Plasmacytoma
-
Primary Amyloidosis
Exclusion Criteria:
< 18 years of age
Have not been diagnosed with one of the following:
Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Indiana University Simon Cancer Center | Indianapolis | Indiana | United States | 46202 |
Sponsors and Collaborators
- Indiana University
Investigators
- Principal Investigator: Mohammad Abu Zaid, MD, Indiana University School of Medicine
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IUSCC-0661